Array Technologies, Inc.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
ARRY$4.73-8.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (unaudited)
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating activities | ||
| Net income | $26,343 | $60,008 |
| Adjustments to reconcile net income to cash provided by operating activities: | ||
| Provision for bad debts | 3 | 1,910 |
| Deferred tax benefit | (2,637) | (246) |
| Depreciation and amortization | 19,851 | 12,188 |
| Amortization of developed technology and backlog | 11,229 | 7,279 |
| Amortization of debt discount and issuance costs | 1,768 | 3,457 |
| Gain on extinguishment of debts, net | — | (14,207) |
| Equity-based compensation | 8,520 | 6,696 |
| Change in fair value of contingent consideration | (145) | — |
| Warranty provision | 7,013 | 5,336 |
| Inventory reserve | 1,197 | 2,682 |
| Other non-cash | 690 | 10 |
| Changes in operating assets and liabilities | 18,026 | (54,331) |
| Net cash provided by operating activities | 91,858 | 30,782 |
| Investing activities | ||
| Purchase of property, plant and equipment | (15,144) | (8,983) |
| Net cash used in investing activities | (15,144) | (8,983) |
| Financing activities | ||
| Proceeds from issuance of other debt | 38,254 | 57,064 |
| Proceeds from issuance of convertible notes | — | 345,000 |
| Premium paid on capped call | — | (35,087) |
| Fees paid on issuance of convertible notes | — | (10,434) |
| Repayments of other debt | (51,003) | (54,754) |
| Repayments of term loan facility | — | (233,875) |
| Repayments of convertible notes | — | (78,363) |
| Contingent consideration payments | (2,574) | (1,204) |
| Other financing | (1,806) | (1,123) |
| Net cash used in financing activities | (17,129) | (12,776) |
| Effect of exchange rate changes on cash and cash equivalent balances | 1,733 | 5,606 |
| Net change in cash and cash equivalents and restricted cash | 61,318 | 14,629 |
| Cash and cash equivalents, and restricted cash beginning of period | 245,984 | 364,141 |
| Cash and cash equivalents and restricted cash, end of period | $307,302 | $378,770 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.